SCHEMBL5221466

SCHEMBL5221466

Cc1coc2c(N3CCCC3=O)cc(C(=O)O)cc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.44
HSD17B10 Q99714 1/20 0.44
CYP2C9 P11712 4/20 0.43
CYP3A4 P08684 2/20 0.43
ALDH1A1 P00352 3/20 0.43
HPGD P15428 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C19 P33261 1/20 0.42
CDK2 P24941 1/20 0.40
USP2 O75604 1/20 0.39
IP6K1 Q92551 1/20 0.39
IP6K3 Q96PC2 1/20 0.39
IP6K2 Q9UHH9 1/20 0.39
CTSD P07339 1/20 0.39
BACE1 P56817 1/20 0.39
BACE2 Q9Y5Z0 1/20 0.39
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5223336 0.90 CYP2C9 (0.44) GAAHSD17B10CYP2C9CYP3A4ALDH1A1
SCHEMBL5222894 0.85 CTSD (0.51) GAAHSD17B10CYP2C9CYP3A4ALDH1A1
SCHEMBL5385122 0.76 HSD17B10 (0.44) GAAHSD17B10CYP2C9CYP3A4ALDH1A1
SCHEMBL5217658 0.76 CTSD (0.49) HSD17B10CYP2C9CYP3A4ALDH1A1HPGD
SCHEMBL5219361 0.75 GAA (0.44) GAAHSD17B10CYP2C9CYP3A4ALDH1A1
SCHEMBL5217707 0.72 ALDH1A1 (0.54) GAAHSD17B10CYP2C9CYP3A4ALDH1A1
SCHEMBL5222262 0.72 ALDH1A1 (0.50) GAAHSD17B10CYP2C9CYP3A4ALDH1A1
SCHEMBL7934713 0.72 GAA (0.58) GAAHSD17B10CYP2C9CYP3A4ALDH1A1
SCHEMBL4825042 0.69 GAA (0.56) GAAHSD17B10CYP2C9CYP3A4ALDH1A1
SCHEMBL1479266 0.69 CYP2C9 (0.55) GAAHSD17B10CYP2C9CYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-B1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2007-02-21 EP disclosed